IgA nephropathy (Berger's disease)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Causes

By Mayo Clinic staff

CLICK TO ENLARGE

Illustration showing kidney cross section 
Kidney cross section

Your kidneys are two bean-shaped, fist-sized organs located at the small of your back, one on each side of your spine. Each kidney contains tiny blood vessels (glomeruli) that filter waste, excess water and other substances from your blood as they pass through your kidneys. The filtered blood re-enters your bloodstream, while the waste material passes into your bladder and out of your body when you urinate.

Immunoglobulin A (IgA) is an antibody that plays a key role in your immune system by attacking invading pathogens and fighting infections. But in IgA nephropathy, this antibody collects in the glomeruli, causing inflammation (glomerulonephritis) and gradually affecting their filtering ability.

Researchers don't know exactly what causes IgA deposits in the kidneys, but these conditions or factors may be associated with the development of IgA nephropathy:

  • Genes, because IgA nephropathy is more common in some families and in certain ethnic groups
  • Liver diseases, including cirrhosis, a condition in which scar tissue replaces normal tissue within the liver, and chronic hepatitis B and C infections
  • Celiac disease, a digestive condition triggered by eating gluten, a protein found in most grains
  • Dermatitis herpetiformis, an itchy, blistering skin disease that stems from gluten intolerance
  • Infections, including HIV infection and some bacterial infections
References
  1. IgA nephropathy. National Institute of Diabetes and Digestive and Kidney Diseases. http://kidney.niddk.nih.gov/kudiseases/pubs/iganephropathy/. Accessed March 15, 2013.
  2. Nephrotic syndrome. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/print/sec17/ch235/ch235b.html. Accessed March 15, 2013.
  3. Barratt J, et al. Clinical presentation and diagnosis of IgA nephropathy. http://www.uptodate.com/home. Accessed March 15, 2013.
  4. Barratt J, et al. Pathogenesis of IgA nephropathy. http://www.uptodate.com/home. Accessed March 15, 2013.
  5. Anderson CF (expert opinion). Mayo Clinic, Rochester, Minn. March 18, 2013.
  6. Cattran DC, et al. Treatment and prognosis of IgA nephropathy. http://www.uptodate.com/home. Accessed March 15, 2013.
  7. Lv J, et al. Corticosteroid therapy in IgA nephropathy. Journal of the American Society of Nephrology. 2012;23:1108.
  8. IgA nephropathy. National Kidney Foundation. http://www.kidney.org/atoz/content/iganeph.cfm. Accessed March 15, 2013.
  9. Your guide to lowering blood pressure. National Institutes of Health. http://www.nhlbi.nih.gov/health/public/heart/hbp/hbp_low/index.htm. Accessed March 16, 2013.
  10. Miller HL. Decision Support System. Mayo Clinic, Rochester, Minn. March 8, 2013.
  11. PEERS Lending Support. National Kidney Foundation. http://www.kidney.org/patients/peers/index.cfm. Accessed March 16, 2013.
  12. Fervenza FC (expert opinion). Mayo Clinic, Rochester, Minn. March 18, 2013.
DS00856 April 19, 2013

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger